Back to News
Market Impact: 0.2
RFK Jr. Deputy Nominee Firmly Backs Vaccines in Senate Hearing
Source: Bloomberg
Healthcare & BiotechManagement & Governance
President Donald Trump's nominee for the No. 2 role at the top US health agency strongly endorsed the safety of the measles vaccine. The position contrasts with vaccine doubts previously raised by Trump and Health Secretary Robert F. Kennedy Jr., signaling potential internal policy tension but limited immediate market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Beta Bionics prices $150M public offering at $17.25/share
- Inside South Korea’s university programs offering a direct route to Samsung and SK Hynix
- A sharp stock market decline could lie around the corner, Wells Fargo warns
- FG Nexus repurchases 46% of outstanding common shares
- Indonesian Power Politics, Not Markets, Forced Out Finance Chief
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data
- Best AI Stock Research Tools for Professional Investors